This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment about the drug

One of the key objectives of the report was to estimate the existing market size and the future opportunity of therapies for Pemphigus vulgaris, over the next decade. Based on multiple parameters, such as disease prevalence, anticipated adoption of the forecasted therapies and the likely selling price of such therapeutic products, we have provided informed estimates on the evolution of the market for the period 2020-2030. It features an in-depth analysis, highlighting the current treatment pract...

This report provides an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Neuromyelitis optica. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the drug

This report provides an informed opinion on the likely adoption of therapeutics designed to treat peanut allergy. It features an in-depth analysis, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape and its growth prospects over the coming years, providing information about the product

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

This report provides an informed opinion on the likely adoption of therapeutics designed to treat multi-drug resistant tuberculosis. It features an in-depth analysis, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product

The global proteome profiling market, valued at USD 8 billion in 2025, is projected to reach USD 10 billion in 2026 and USD 16 billion by 2030, with a 12.2% CAGR during the forecast period 2026 to 2030. Proteome profiling refers to the large-scale, high-throughput analysis of biological samples for the detection, identification, and functional characterization of resident proteins. Currently, the demand for proteome profiling is high, given the growing pipeline of peptide synthesis. In fact, si...

The high energy / hazardous chemistry market is estimated to be worth $14 billion in 2020 and is expected to grow at CAGR of 8% during the forecast period. In pharmaceutical contract manufacturing, the use of certain hazardous chemical reactions has been shown to enable developers to optimize existing production processes, as well as improve yields. As a result, the number of process steps are essentially reduced, when compared to using conventional synthesis chemistries. However, they are usua...

The healthcare digital marketing market is estimated to be worth $305 million in 2020 and is expected to grow at CAGR of 26% during the forecast period. Advent of smartphones coupled to the easy accessibility of information on the internet, has rendered it crucial for companies to establish a digital presence. In fact, a recent study stated that digital advertising is expected to account for around 50% of the overall global advertisement spend by 2021. Further, it is encouraging to note that ove...

The vector purification market is estimated to be worth $155 million in 2020 and is expected to grow at compounded annual growth rate (CAGR) of 21% during the forecast period. Since the approval and launch of cell and gene therapy products, such as Zolgensma

The endocannabinoid system market is estimated to be worth $5.4 billion in 2030, growing at a CAGR of 28% during the forecast period. It is worth mentioning that chronic conditions, such as arthritis, cancer, diabetes, and heart disease are known to affect approximately 133 million Americans, representing over 40% of the total US population. This number is projected to grow to 157 million by the end of 2020. Notably, drugs that offer symptomatic relief are the only treatment option currently ava...

The China biologics contract manufacturing market, valued at USD 5.7 billion in 2025, is projected to reach USD 6.5 billion in 2026 and USD 15.5 billion by 2035, with a 10.2% CAGR during the forecast period 2026 to 2035. It is worth noting that till date, over 25 biologics and biosimilar products have been approved in China. In addition, close to 1,000 clinical trials, investigating a variety of biologics and biosimilars for treating a diverse range of diseases, are presently underway in this re...

New coronavirus (COVID-19) is a previously unidentified strain of coronavirus, that first emerged in the Chinese city of Wuhan in December 2019. On 30th January 2020, the WHO declared the coronavirus outbreak as a global health emergency. In fact, the virus is estimated to have infected more than 45,000 individuals, around the globe (estimates till the second week of February 2020). Consequently, more than 35 pharmaceutical / biotechnology companies, government agencies, and research institutes...

The China pharmaceutical contract manufacturing market is estimated to be worth $5.5 billion in 2020 and is expected to grow at CAGR of 9% during the forecast period. Over the past few decades, the pharmaceutical market in China has evolved into the second largest in the world; as per certain industry experts, it is estimated to surpass USD 300 billion by the end of 2020. Moreover, the number of FDA approved API CMO manufacturing facilities in the region has doubled during the period 2010-2019....

The cell reprogramming market is estimated to be worth $1.16 billion in 2020 and is expected to grow at compounded annual growth rate (CAGR) of 8% during the forecast period. Stem cell-based treatments are known for their ability to replace damaged cells and tissues, thereby, effectively reversing the adverse physiological effects they cause. The discovery of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka

The fragment based drug discovery market is estimated to be worth $596 million in 2020 and is expected to grow at CAGR of 11% during the forecast period. Drug discovery and development is a complex and tedious process that requires a significant amount of resources and capital investment (~USD 2.6 billion). Specifically, in 2019, R&D spending was estimated to be around USD 182 billion, with more than 16,000 drug molecules evaluated during the course of the whole year. As a result, the industry...

The global prefilled syringe fill finish manufacturing market, valued at USD 1.8 billion in 2025, is projected to reach USD 2.0 billion in 2026 and USD 2.9 billion by 2030, with a 9.4% CAGR during the forecast period 2026 to 2030. Prefilled syringe fill finish manufacturing is considered to be one of the most crucial steps in the pharmaceutical production process. Proper prefilled syringe fill finish, carried out under aseptic conditions, is a necessity for not only maintaining pharmacological e...

The peptide drug discovery market is estimated to be worth $560 million in 2020 and is expected to grow at compounded annual growth rate (CAGR) of 10.5% during the forecast period. Over the past few years, peptides and macrocycle-based pharmacological interventions have gained a lot of attention from clinical researchers. In fact, more than 60 peptide-based therapies and macrocycle drug molecules have been approved till date, across the globe. In addition, more than 400 peptide based drugs are...

The computer aided drug discovery market is estimated to be worth $29 million in 2020 and is expected to grow at CAGR of 15.6% till 2030. The process of drug development, beginning from the discovery of a pharmacological lead to its commercial launch, is estimated to take around 10-15 years, involving capital investments in the range of USD 4-10 billion. Over time, the complexities of drug discovery, have increased; this is especially true for large molecules, which are inherently more complex t...